AI assistant
Merck & Co., Inc. — Director's Dealing 2019
May 8, 2019
284_dirs_2019-05-07_e48a0fbd-d559-481f-84b7-46fb5ed205e4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-01-01
Reporting Person: Nally Michael (EVP, Chief Marketing Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 100.0000 | Direct |
| Common Stock - 401(k) Plan | 1365.9535 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $ | 2021-05-04 | Common Stock (3896.0000) | Direct | |
| Restricted Stock Unit | $ | 2019-05-10 | Common Stock (1811.0000) | Direct | |
| Restricted Stock Unit | $ | 2021-10-30 | Common Stock (6862.0000) | Direct | |
| Restricted Stock Unit | $ | 2020-05-05 | Common Stock (2345.0000) | Direct | |
| Stock Option (right to buy) | $54.6800 | 2026-05-09 | Common Stock (7471.0000) | Direct | |
| Stock Option (right to buy) | $57.7500 | 2028-05-03 | Common Stock (27447.0000) | Direct | |
| Stock Option (right to buy) | $63.9700 | 2027-05-04 | Common Stock (14266.0000) | Direct |
Footnotes
F1: The original Form 3, filed on January 10, 2019, is being amended by this Form 3 amendment solely to correct the total number of shares beneficially owned by the reporting person to include 100 shares of Merck common stock held in a joint account with the reporting person and the reporting person's parent.
F2: Includes shares acquired and dividends earned through January 1, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.
F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F4: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F5: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
F6: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.
F7: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F8: The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/19 and 5/5/2020.